Pharm Exec12d
Exploring the Advantages of Innovative Early Phase Trial Design
In early phase trials innovative designs offer potential for improvements in efficiency and decision-making. Determining the ...
Navigating Regulatory Complexities in Drug Trials for Celiac Disease and Other Rare Conditions
Bushra Sumra's career highlights the profound impact that expertise in clinical research and regulatory compliance can have ...
Nasdaq11d
Immutep Limited Announces Transition to Phase III with Regulatory Approval for TACTI-004 Trial in Non-Small Cell Lung Cancer
With a strong cash position of A$159.26 million, the company is well-funded for future operations and clinical trials. Immutep received regulatory approval for its pivotal TACTI-004 Phase III ...
Business Wire12d
KORU Medical Systems Announces Phase III Clinical Trial Collaboration for a New Drug Indication in Nephrology
The Phase III trial aims to assess ... subcutaneous market with multiple new drugs entering clinical trials and several others receiving regulatory approval. With over 2 million infusions ...
Cannovation Clinical Research Partners Announces New Divisions And Leadership To Drive Innovation In Drug Development
Cannovation Clinical Research Partners Psychedelic Division We are pleased to announce the new changes within our organization as of ...
Viking Therapeutics targets Phase 3 trials for VK2735 in Q2 2025 amid strong clinical progress
CEO Brian Lian highlighted 2024 as an exceptionally busy year, with successful results from four studies, including the Phase 2 VENTURE trial for subcutaneous VK2735, which demonstrated up to 14.7% ...